04 July 2022: Articles
Unusual clinical course, Challenging differential diagnosisConner V. Lombardi1ABCEF*, Logan D. Glosser 1ACE, Spiro Veria1ACF, Wade Hopper 2EF, Prabath Herath-Mudiyanselage3E
Am J Case Rep 2022; 23:e935434
BACKGROUND: Gastric adenocarcinoma is a common malignancy, representing the third most common cause of cancer-related death globally. Most patients are initially asymptomatic, but as the cancer progresses, patients typically present with vague gastrointestinal complaints, including early satiety, heart burn, vomiting, or abdominal pain. Metastatic gastric cancer is relatively uncommon, with ~26% of patients having metastasis to a single site and 13% having metastases to multiple sites. The most common site of metastasis is the liver, followed by peritoneum, lung, and bone.
CASE REPORT: In this case report we describe a 73-year-old man who presented with shortness of breath, found to have large hiatal hernia along with segmental branch pulmonary embolism, bilateral pleural effusion, and diffuse interlobular septal thickening. The pleural effusion was later found to be malignant in nature and the patient was diagnosed with metastatic stage IV infiltrative gastric adenocarcinoma with metastasis to the lung and bone. Notably, the patient had no hepatic involvement.
CONCLUSIONS: This represents a unique case, as only 2% of malignant pleural effusions are attributable to gastric cancer. Furthermore, malignant pleural effusion is an extremely rare initial presentation of gastric adenocarcinoma, especially without liver involvement, with few existing cases documented in the literature. This case demonstrates that gastric cancer should be included on the differential diagnosis as a rare cause of pleural effusion.
Keywords: Adenocarcinoma, Pleural Effusion, Malignant, Positron-Emission Tomography, Aged, Exudates and Transudates, Humans, Male, Pleural Effusion, Stomach Neoplasms
Gastric cancer is the third most common cause of cancer-related deaths worldwide . While incidence and mortality have been on a slow decline, gastric cancer still causes significant burden to patients and the healthcare system . Between 90% and 95% of all diagnosed gastric cancer cases are gastric adenocarcinoma . The initial presentation of gastric cancer typically includes broad gastrointestinal complaints (eg, dysphagia, gastrointestinal bleeding, vomiting, abdominal pain) . Pulmonary metastasis is relatively uncommon, comprising only 15% of all gastric cancer metastases . Pleural effusion is an even more rare initial presentation, as only 2% of malignant plural effusions are attributable to gastric cancer and the current literature contains fewer than 10 instances of pleural effusion as the presenting symptom of gastric cancer [5–8]. Pulmonary metastases from gastric carcinoma are typically a late manifestation of incurable disease at the time of presentation. The following is a case of pleural effusion as the presenting symptom of stage IV gastric adenocarcinoma from an academic hospital. Reporting for this manuscript is in line with the CARE Case Report Guidelines .
Two weeks after discharge, an outpatient positron emission tomography (PET)/CT scan revealed increased activity in bilateral lung fields and diaphragmatic surfaces (Figure 3), along with bone metastases. Notably, there was no increased activity in the stomach or duodenum. The CT also revealed ground-glass opacities in the bilateral upper lung fields along with interlobular septal thickening. Due to the pulmonary imaging findings combined with reported worsening shortness of breath, the patient was sent to the ED.
From the ED the patient was admitted for acute hypoxic respiratory distress due to worsening malignant pleural effusion. He was placed on 5L NC after which arterial blood gas (ABG) returned pH of 7.37, PCO2 of 41 mmHg, PO2 of 49 mmHg (moderate hypoxemia), and HCO3 of 24 mmol/L. Pulmonary was consulted and the patient was transferred to the intensive care unit (ICU) for higher- level care. The patient stated that he had progressive worsening of his shortness of breath with increased anxiety over the past few days. He was unable to lay flat and woke up panicking shortly after falling asleep. Decreased dietary in-take was also noted. Physical exam revealed decreased bibasilar breath sounds, widespread bilateral rales, and tachycardia.
The patient was started on high-flow oxygen and Eliquis was held in anticipation of thoracentesis and/or chest tube placement. The patient developed acute urinary retention and left-sided hydronephrosis requiring foley placement. Oncology deemed chemotherapy was inappropriate due to the patient’s worsening clinical status, thus palliative care was consulted. The following morning on admission day 1, the patient required intubation. Subsequent renal failure and shock developed, requiring vasopressors and continuous renal replacement therapy.
On admission day 2, bilateral pigtail chest tubes were placed, which returned pleural fluid consistent with metastatic adenocarcinoma. Overnight, the patient’s endotracheal tube (ETT) cuff blew and had to be exchanged. The following morning, on admission day 3, the patient had high plateau pressures and bedside bronchoscopy showed significant mucous plugging. The patient had increased agitation requiring sedatives and paralytics to maintain ventilator compliance.
On admission day 4, the patient had worsening leukocytosis and appeared to be progressing into acute respiratory distress syndrome (ARDS). The antibiotic regimen was escalated to Vancomycin and Cefepime with a low tidal volume ventilator strategy. On admission day 5, an attempt to remove the patient from sedation was unsuccessful due to worsening tachypnea. Life-support measures were withdrawn and the patient was terminally extubated.
Gastric adenocarcinoma is the most common type of gastric cancer and commonly arises in the distal stomach with a long precancerous phase [1,10]. The leading risk factor for gastric adenocarcinoma is
The symptomatic presentation with metastatic adenocarcinoma of this case is unique. Metastatic gastric cancer is relatively uncommon, with ~26% of patients having metastasis to a single site and 13% having metastases to multiple sites . A variety of testing and imaging showed multiple sites of metastasis for our patient, with stomach and duodenal biopsies consistent with invasive gastric adenocarcinoma and PET/CT imaging showing evidence of lung, pleural, diaphragmatic, and bony metastasis. Pleural and bony metastases are also quite unique, as the most frequent sites of gastric cancer metastasis are the liver (48%) and the peritoneum (32%), and more rarely the lung (15%) and bone (12%) . Interestingly, the PET scan after the patient’s initial hospitalization did not demonstrate increased uptake in the stomach or duodenum despite biopsy-proven disease. While PET scan has significant utility for early detection of various PET-avid tumors, its utility with gastric carcinomas is widely debated due to varying sensitivities and current lack of guidelines for gastric carcinoma work-up . Additionally, although PET scans may be used to complement anatomic imaging in gastric cancer, its utility in staging is not well understood and is not recommended by most international guidelines . When surveilling for distant metastasis of gastric cancer, PET scans are less sensitive but significantly more specific than contrast-enhanced CT scans . Therefore, PET scans should be used in concert with other modalities so as to not understage the degree of tumor spread.
Initial symptoms of gastric cancer include some mix of vague gastrointestinal symptoms. Symptoms of gastric cancer are typically defined as either ‘early stage’ or ‘alarm’ symptoms . Identifying and diagnosing gastric cancer at an early stage is difficult for 3 main reasons: (1) many gastric cancers have long precancerous phases, (2) the early stages of most gastric cancers are asymptomatic, and (3) when patients experience ‘early stage’ symptoms they are often vague and mistaken for more benign gastrointestinal manifestations. ‘Alarm’ symptoms alert the patient to the underlying issue and bring the patient to receive a further workup. Common alarm symptoms include dysphagia, weight loss, and palpable abdominal mass. Alarm symptoms are typically insidious from the standpoint that when noticeable symptoms arise, the underlying cancer has typically progressed or metastasized, conferring a worse prognosis. About 62% of gastric cancers are diagnosed after metastasis has occurred, procuring a 5-year survival rate of 32% . Our patient aligns with this concept, initially presenting with alarm symptoms of worsening shortness of breath, intermittent pleurisy, dry cough, dysphagia with solid food, and 10-pound weight loss, leading to the eventual discovery of malignant pleural effusion due to late-stage gastric adenocarcinoma. It is important to consider, in this case, that the dysphagia was at least in part due to the large hiatal hernia. It is also important to consider there were multiple compounding factors that contributed to the shortness of breath in this case. While the malignant pleural effusion may have led in part to the shortness of breath experienced by this patient, it may also have been caused or exacerbated by the segmental branch pulmonary embolism or the diffuse interlobular septal thickening consistent with congestive heart failure. Nonetheless, the shortness of breath prompted workup for pulmonary disease, leading to the discovery of pleural effusion, which diagnostic thoracentesis confirmed to be caused by gastric adenocarcinoma.
The segmental branch pulmonary embolism in itself is an interesting component of this case, as it may have also been caused by the hypercoagulable state induced by stage VI gastric adenocarcinoma. While in this case report we consider pleural effusion to be the ‘initial presentation’ due to specific cytology and histology demonstrating its direct malignant cause from the gastric adenocarcinoma, it is completely plausible that the pulmonary embolism was also caused by the gastric adenocarcinoma. The hematology/oncology consult on the patient’s second admission noted the likely cause of the pulmonary embolism to be hypercoagulable state due to adenocarcinoma. This well-studied phenomenon of hypercoagulation during malignancy is due, in large part, to increased secretion of procoagulant substances and inflammatory cytokines into the bloodstream, and thromboembolism occurs in around 13% of patients with gastric cancer .
The initial presentation of pulmonary disease due to gastric adenocarcinoma-related malignant pleural effusion is incredibly rare, and to our knowledge only 6 such cases have been documented in the literature [6–8]. While adenocarcinomas of the stomach are the most common cause of malignant pleural effusions out of all gastrointestinal tract cancers, rarely is this the initial manifestation of the carcinoma, as the gastric cancer is typically already diagnosed by the stage lung metastasis would occur . The present case report is limited in that it only represents 1 patient; furthermore, it is difficult to condense the complexity of this patient’s case within a single report. The case report holds value because it demonstrates the potential for occult gastric adenocarcinoma to present overtly though pulmonary symptoms.
This case demonstrates a rare initial presentation of gastric adenocarcinoma-related malignant pleural effusion and highlights that gastric adenocarcinoma should be included on the differential diagnosis as a rare cause of malignant pleural effusion.
FiguresFigure 1.. CT angiogram of chest showing right lower lobe segmental branch pulmonary embolism demonstrated by the red arrow, diffuse interlobular septal thickening with associated ground glass, bilateral pleural effusion, and massive hiatal hernia causing compression of the left atrium and pulmonary veins. Figure 2.. Series of images from esophagogastroduodenoscopy showing in image A. An irregular Z-line and a 4 cm hiatal hernia, in image B. A 2-cm tongue of salmon-colored mucosa in the esophagus, and in image C. Diffusely thickened circumferential edematous nodular gastric folds. Figure 3.. PET/CT scan with increased activity along the right posterior pleural surface, bilateral diaphragmatic surfaces, left posterior acetabular bone, right SI joint, S2 segment of the sacrum, and the spine between T11 and L5. Notably, no increased activity is seen in the stomach or duodenum.
1.. Rawla P, Barsouk A, Epidemiology of gastric cancer: Global trends, risk factors and prevention: Prz Gastroenterol, 2019; 14(1); 26-38
2.. Maconi G, Manes G, Porro GB, Role of symptoms in diagnosis and outcome of gastric cancer: World J Gastroenterol, 2008; 14(8); 1149
3.. Riihimäki M, Hemminki A, Sundquist K, Metastatic spread in patients with gastric cancer: Oncotarget, 2016; 7(32); 52307-16
4.. Hwang EJ, Jang JY, Kim YW, A case of early gastric cancer with solitary metastasis to the pleura: Clin Endosc, 2013; 46(6); 666-70
5.. Dicken BJ, Bigam DL, Cass C, Gastric adenocarcinoma: Review and considerations for future directions: Ann Surg, 2005; 241(1); 27-39
6.. Roussos A, Patsopoulos D, Philippou N, Pleural effusion as the initial manifestation of gastric adenocarcinoma: A report of four cases: Scand J Gastroenterol, 2001; 36(7); 784
7.. Šťastná N, Brat K, A rare coincidence of a chylothorax and a hydro-thorax caused by gastric adenocarcinoma – a case report: Vnitr Lek, 2020; 66(7); 43-45
8.. Nagano N, Suzuki M, Tamura K, Refractory chylothorax and lymphedema caused by advanced gastric cancer: Intern Med, 2019; 58(21); 3143-48
9.. , “Care Case Report Guidelines.“ CARE Case Report Guidelines, CARE https://www.care-statement.org/
10.. Roder D, The epidemiology of gastric cancer: Gastric Cancer, 2002; 5(S1); 5-11
11.. Herbella FA, Neto SP, Santoro IL, Figueiredo LC, Gastroesophageal reflux disease and non-esophageal cancer: World J Gastroenterol, 2015; 21(3); 815-19
12.. Hopkins S, Yang GY, FDG PET imaging in the staging and management of gastric cancer: J Gastrointest Oncol, 2011; 2(1); 39-44
13.. Van Cutsem E, Sagaert X, Topal B, Gastric cancer: Lancet, 2016; 388(10060); 2654-64
14.. Altini C, Niccoli Asabella A, Di Palo A, 18F-FDG PET/CT role in staging of gastric carcinomas: Comparison with conventional contrast enhancement computed tomography: Medicine (Baltimore), 2015; 94(20); e864
15.. “Stomach Cancer – Statistics.” Cancer.Net, 3 Mar. 2021. https//www.cancer.net/cancer-types/stomach-cancer/statistics
16.. Caine GJ, Stonelake PS, Lip GY, Kehoe ST, The hypercoagulable state of malignancy: Pathogenesis and current debate: Neoplasia, 2002; 4(6); 465-73
30 Sep 2023 : Case reportA 33-Year-Old Man with a 22-Year History of Nephrotic Syndrome Due to Minimal Change Disease Exacerbated Fo...
Am J Case Rep In Press; DOI: 10.12659/AJCR.941621
29 Sep 2023 : Case reportIdiopathic Dilated Cardiomyopathy, Cardiac Failure, and Global Cerebral Atrophy Due to Reduced Cerebral Art...
Am J Case Rep In Press; DOI: 10.12659/AJCR.940892
28 Sep 2023 : Case reportLifetime Follow-Up of a Patient with Metastatic Prostate Cancer Undergoing Multiple Surgical Resections: A ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.941668
Most Viewed Current Articles
06 Dec 2021 : Case reportLipedema Can Be Treated Non-Surgically: A Report of 5 Cases
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case reportEdwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...
Am J Case Rep 2021; 22:e934347
13 Jul 2022 : Case reportWhistling Scrotum: An Unusual Presentation of Pneumomediastinum in the Setting of an Open Scrotal Wound
Am J Case Rep 2022; 23:e936441